This content is in French.
2nd Gene Therapy for Ophthalmic Disorders 2021
21 Septembre 2021 · 3 joursOnline, United StatesOphthalmologyEnglish
OnlineAbout this congress
Discover novel vectors and administration routes for optimal retinal delivery with 30+ world class speakers from the likes of GenSight Biologics, Biogen, Gyroscope Therapeutics, Novartis, Horama and REGENXBIO.